Azzad Asset Management Inc /Adv Jazz Pharmaceuticals PLC Transaction History

Azzad Asset Management Inc /Adv

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Apr 01, 2024	SELL	$129.72 - $159.85 $809,712 - $997,783	-6,242 Closed	0 $0
Q2 2022 Apr 01, 2024	BUY	$141.59 - $168.66 $883,804 - $1.05 Million	6,242 New	6,242 $689 Million
Q3 2020 Apr 01, 2024	SELL	$105.46 - $144.13 $658,281 - $899,659	-6,242 Closed	0 $0
Q2 2020 Apr 01, 2024	SELL	$95.68 - $121.88 $95 - $121	-1 Reduced 0.02%	6,242 $689 Million
Q1 2020 Apr 01, 2024	SELL	$87.74 - $152.74 $547,673 - $953,403	-6,242 Reduced 50.0%	6,243 $623 Million
Q3 2019 Apr 01, 2024	BUY	$125.18 - $143.24 $781,623 - $894,390	6,244 Added 100.05%	12,485 $1.49 Billion
Q2 2019 Apr 01, 2024	BUY	$125.55 - $144.48 $169,743 - $195,336	1,352 Added 27.65%	6,241 $890 Million
Q4 2018 Apr 01, 2024	BUY	$115.94 - $166.74 $105,505 - $151,733	910 Added 22.87%	4,889 $606 Million
Q3 2018 Apr 01, 2024	BUY	$161.01 - $180.57 $640,658 - $718,488	3,979 New	3,979 $669 Million

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Azzad Asset Management Inc /Adv, based on Form 13F filings with the SEC.

Stay updated on Azzad Asset Management Inc /Adv with notifications on news.